Fukuoka, Japan

Mitihiro Sugano

This inventor holds 1 USPTO granted patent. Top assignee: Sagami Chemical Research Center. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitihiro Sugano. Retrieved from https://idiyas.com/inventor/mitihiro-sugano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mitihiro Sugano

Introduction

Mitihiro Sugano is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of hepatitis. His work has garnered attention for its potential impact on public health.

Latest Patents

Mitihiro Sugano holds one patent, which is a method for treating hepatitis. This innovation showcases his commitment to addressing critical health issues through scientific research and development.

Career Highlights

Sugano is currently employed at the Sagami Chemical Research Center. His role at this esteemed institution allows him to engage in cutting-edge research and collaborate with other experts in the field.

Collaborations

Some of his notable coworkers include Kazunaga Yazawa and Tomohito Hamasaki. Their collective expertise contributes to the innovative environment at the Sagami Chemical Research Center.

Conclusion

Mitihiro Sugano's work exemplifies the spirit of innovation in medical research. His contributions, particularly in hepatitis treatment, highlight the importance of scientific advancements in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…